IFNG and melanoma: Together with the flow-based data shown above, scRNA-seq analysis strongly suggests that DCP-IL-12/FLT3L instigated an IFNγ response that contributed to limiting tumor growth, at least partly, through effects on melanoma and myeloid cells.